Our Team
Ideal background and experience in building businesses
David Reckeweg-Lecompte, Co-CEO, Co-Founder & Director (Germany)
CEO of Dr. Reckeweg, a German Pharma company with 75+ years in manufacturing plant-based medicinal products; partner of Eurox for Cannabis-extracted products; President of European Coalition on Homeopathic & Anthroposophic Medicinal Products (ECHAMP); MBA
Josh Gerstein, Co-CEO, Co-Founder & Director (Canada)
Former executive of Canadian LP, through licensing, commissioning and sales stages; Merchant Banker & Corporate Strategist with extensive experience in private-public company transitions; MBA/JD
Bernhard Babel, President, Co-Founder & Director (Germany)
Co-Founder of Eurox, a medical Cannabis manufacturer in Europe; former Partner in McKinsey’s Regulatory & Strategy group, and CEO of McKinsey 100+ person division; PhD
Neil Smith, Chairman & Co-Founder (UK)
Co-Founder of Eurox; former senior executive from Deutsche Bank overseeing 10,000+ employees; former consultant to McKinsey; held numerous board positions; track record of leading large & complex projects
Estela Figueiredo, Research & Product Development (Portugal)
EU QP; Master’s in analytical, clinical and forensic toxicology – Thesis focused on components of mushrooms and underlying soils; former production lead at Novartis
Dr. Carlos Ribeiro, Research & Product Development (Portugal)
Research and product development in pharmaceutical engineering, medicinal chemistry and chemical biology; PhD in Pharmacy (Pharmaceutical and Therapeutic Chemistry)
Prof. Dr. Johannes Bartholomaeus, Product Development (Germany)
Led pharmaceutical development and manufacturing of investigational medicinal products for Gruenenthal, a major German pharmaceutical player; PhD in Pharmaceutical Technology
Silvia Dickhut, Clinical Programs (Germany)
25 years with Gruenenthal in drug development; multi-disciplinary expertise across research, technical (CMC) and clinical development, regulatory affairs, lifecycle management; M.Sc